missing translation for 'onlineSavingsMsg'
Learn More

Novus Biologicals™ SLC6A14 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals™ NBP3-27859-100ul

 View more versions of this product

Product Code. 30041561

  • 382.00 EUR / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

SLC6A14 Polyclonal antibody specifically detects SLC6A14 in Human,Mouse,Rat samples. It is validated for ELISA,Western Blot,Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SLC6A14
Polyclonal
Western Blot 1:500 - 1:2000, ELISA 1:40000, Immunohistochemistry-Paraffin 1:100-300
Amino acid transporter ATB0+, amino acid transporter B0+, BMIQ11, OBX, sodium- and chloride-dependent neutral and basic amino acid transporter B(0+), solute carrier family 6 (amino acid transporter), member 14, solute carrier family 6 (neurotransmitter transporter), member 14, Solute carrier family 6 member 14
Synthesized peptide derived from the C-terminal region of human SLC6A14. (Uniprot #: Q9UN76)
100 μL
Cancer, Endocrinology, Signal Transduction
11254
Store at -20°C. Avoid freeze/thaw cycles.
IgG
ELISA, Western Blot, Immunohistochemistry (Paraffin)
Unconjugated
PBS, 50% glycerol, 0.5% BSA
Rabbit
Antigen Affinity-purified
RUO
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.